Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - DEPRECIATION & AMORTIZATION
Depreciation & Amortization RARE - Ultragenyx Pharmaceutical Inc.
35.5 M
LAST VALUE
39.67%
2 YEAR CAGR
33.01%
5 YEAR CAGR
48.45%
10 YEAR CAGR